Targeting persons with or at high risk for chronic obstructive pulmonary disease by state-based surveillance

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 12, Issue 6, 2015, Pages 680-689

  Pleasants, Roy A ^a   Heidari, Khosrow ^b   Wheaton, Anne G ^c   Ohar, Jill A ^d   Strange, Charlie ^e   Croft, Janet B ^c   Liao, Winston ^g   Mannino, David M ^h   Kraft, Monica ^f  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g North Carolina COPD Taskforce   (United States)

^h UNIVERSITY OF KENTUCKY   (United States)

Author keywords

chronic obstructive pulmonary disease; population surveillance; respiratory symptoms; tobacco exposure; underdiagnosis

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; BREATHING DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COUGHING; DYSPNEA; FEMALE; HEALTH BEHAVIOR; HIGH RISK POPULATION; HUMAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SMOKING; TOBACCO USE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SELF REPORT; SOCIOECONOMICS; UNITED STATES;

ADULT; AGED; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; SELF REPORT; SMOKING; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84951573909     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412555.2015.1043424     Document Type: Article

References (53)

1. U.S. Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. Printed with corrections, January 2014.
2. Murphy SL, Xu J, Kochanek KD. Deaths: Final data for 2010. Natl Vital Stat Rep 2013; 611-699.
3. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-814.
4. Zielinski J, MacNee W, Wedzicha J, et al. Causes of death in patients with COPD and chronic respiratory failure. Monaldi Arch Chest Dis 1997; 52: 43-47.
5. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: Data From the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689.
6. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001; 164: 372-377.
7. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64; 863-868.
8. Price D, Tinkelman DG, Nordyke RJ, et al. Scoring system and clinical application of COPD diagnostic questionnaires. Chest 2006; 129: 1531-1539.
9. Martinez FJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD 2008; 5: 85-95.
10. Hanania NA, Mannino DM, Yawn BP, et al. Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med 2010; 104: 1160-1170.
11. Calverley PM, Nordyke RJ, Halbert RJ, et al. Development of a population-based screening questionnaire for COPD. COPD 2005; 2: 225-232.
12. Price D, Crockett A, Arne M, et al. Spirometry in primary case-identification, diagnosis and management of COPD. Prim Care Respir J 2009; 18: 216-223.
13. Saad N, Sedeno M, Metz K, Bourbeau J. Early COPD diagnosis in family medicine practice: how to implement spirometry? Int J Family Med 2014; Article ID 962901.
14. Ford ES, Croft JB, Mannino DM, et al. COPD Surveillance-United States, 1999-2011. Chest 2013; 144: 284-305.
15. Herrick H, Pleasants R, Wheaton AG, et al. chronic obstructive pulmonary disease and associated health-care resource use-North Carolina, 2007 and 2009. MMWR Morb Mortal Wkly Rep 2012; 61: 143-146.
16. Kosacz NM, Punturieri A, Croxton TL, et al. Chronic obstructive pulmonary disease among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61: 938-943.
17. Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System 2012 Summary Data Quality Report. Available from: http://www.cdc.gov/brfss/annual-data/2012/pdf/SummaryDataQualityReport2012-20130712.pdf (. accessed 3 July, 2013).
18. Mawokomatanda T, Flegel D, Pierannunzi C, et al. Centers for Disease Control and Prevention (CDC). Surveillance for certain health behaviors among states and selected local areas-Behavioral risk factor surveillance system, United States, 2011. MMWR Surveill Summ 2014; 63: 1-149.
19. Wheaton AG, Ford ES, Thompson WW, et al. Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States-National Health and Nutrition Examination Survey 2007-2010. BMC Public Health 2013; 13: 854.
20. Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: A follow-up in middle-aged rural men. Chest 2006; 130: 1129-1137.
21. Ohar JA, Sadeghnejad A, Meyers DA, et al. Do symptoms predict COPD in smokers? Chest 2010; 137: 1345-1353.
22. Agusti A, Calverley PM, Celli B, et al. Characterization of COPD heterogeneity in the ECLIPSE Cohort. Respir Res 2010; 11: 122.
23. Kim V, Han MK, Vance GB, et al. The chronic bronchitis phenotype of COPD: An analysis of the COPD Gene Study. Chest 2011; 140: 626-633.
24. Martinez CH, Kim V, Chen Y, et al. The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med. 2014; 108: 491-499.
25. Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98.
26. Nascimento OA, Camelier A, Rosa FW, et al. Chronic obstructive pulmonary disease is underdiagnosed and undertreated in Sao Paulo (Brazil): Results of the PLATINO Study. Braz J Med Biol Res. 2007; 40: 887-895.
27. Barr RG, Herbstman J, Speizer PE, et al. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002; 155: 965-971.
28. Halldin CN, Doney BC, Hnzido E. Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors. Chron Respir Dis 2014; 1-14.
29. Murgia N, Brisman J, Claesson A, et al. Validity of a questionnaire-based diagnosis of chronic obstructive pulmonary disease in a general population-based study. BMC Pulm Med 2014; 14: 49-55.
30. Tilbert T, Paulose-Ram R, Brody DJ. Lung obstruction among adults 40-79: United States, 2007-2012. NCHS data brief, no. 180. Hyattsville, MD: National Center for Health Statistics, 2015
31. Schirnhofer L, Lamprecht B, Firlei N, et al. Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease. Respiration 2011; 81: 476-482.
32. Heron M. Deaths: Leading causes for 2007. Natl Vital Stat Rep. 2011; 59: 1-95.
33. Heins-Nesvold J, Carlson A, King-Schultz L, Joselyn KE. Patient identified needs for chronic obstructive pulmonary disease versus billed services for care received. Int J Chron Obstruct Pulmon Dis 2008; 3: 415-421.
34. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 155-161.
35. Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of comorbidities. Eur Respir J 2006; 28: 1245-1257.
36. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-969.
37. Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013; 1: 73-83.
38. Van Remoortel H, Hornikx M, Langer D, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2014; 189: 30-38.
39. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD [online] 2014. Available from. http://www.goldcopd.com/ (. accessed 25 May, 2014).
40. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155: 179-191.
41. Bednarek M, Gorecka D, Wielgomas J, et al. Smokers with airway obstruction are more likely to quit smoking. Thorax 2006; 61: 869-873.
42. Tinkelman DG, Price D. Nordyke RJ, Halbert RJ. COPD screening efforts in primary care: What is the yield ? Prim Care Respir J 2007; 16: 41-48.
43. Yawn B, Duvall K, Peabody J, et al. The impact of screening tools on diagnosis of chronic obstructive pulmonary disease in primary care. Am J Prev Med 2014; Sept 15. (Epub ahead of print).
44. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: 1434-1440.
45. Guerra DL, Sherrill C, Venker C, et al. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009; 64: 894-900.
46. Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173: 1326-1334.
47. Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among adults aged 18 and over in the United States, 1998-2009. NCHS data brief, no 63. Hyattsville, MD: National Center for Health Statistics, 2011.
48. Methvin J, Mannino D, Casey B. COPD prevalence in southeastern Kentucky: The burden of lung disease study. Chest 2008; 135: 102-107
49. Leffondré K, Abrahamowicz M, Siemiatycki J, Rachet B. Modeling Smoking History: a Comparison of Different Approaches. Am J Epidemiol 2002; 156: 813-823.
50. Thun MJ, Carter BD, Feskanich D, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013; 368: 351-364.
51. Celli BR, Halbert RJ, Nordyke RJ, Schau B. Airway obstruction in never smokers: results from the third National Health and Nutrition Examination Survey. Am J Med 2005; 118: 1364-1372.
52. Centers for Disease Control and Prevention. Methodologic Changes in the Behavioral Risk Factor Surveillance System in 2011 and Potential Effects on Prevalence Estimates. MMWR Morb Mortal Wkly Rep 2012; 61: 410-413.
53. Centers for Disease Control and Prevention. Public Health Strategic Framework for COPD Prevention. Atlanta, GA: Centers for Disease Control and Prevention, 2011.